These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30719108)

  • 1. Emerging role of long non-coding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A meta-analysis.
    Wang C; Zhang Q; Hu Y; Zhu J; Yang J
    Oncol Lett; 2019 Feb; 17(2):2159-2170. PubMed ID: 30719108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of long noncoding RNA MALAT1 in digestive system malignancies.
    Zhai H; Li XM; Maimaiti A; Chen QJ; Liao W; Lai HM; Liu F; Yang YN
    Int J Clin Exp Med; 2015; 8(10):18099-106. PubMed ID: 26770406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis.
    Shuai P; Zhou Y; Gong B; Jiang Z; Yang C; Yang H; Zhang D; Zhu S
    Springerplus; 2016; 5(1):1721. PubMed ID: 27777857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis.
    Zhang J; Zhang B; Wang T; Wang H
    Int J Clin Exp Med; 2015; 8(4):5499-505. PubMed ID: 26131129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
    Tian X; Xu G
    BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
    Song W; Zhang RJ; Zou SB
    Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
    Song W; Zhang RJ; Zou SB
    Minerva Med; 2016 May; ():. PubMed ID: 27186920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of long noncoding RNA HOTAIR in digestive system malignancies.
    Wang S; Wang Z
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1123-33. PubMed ID: 25754087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical prognostic value of metastasis-associated lung adenocarcinoma transcript 1 in various human cancers: an updated meta-analysis.
    Li Y; Yang Z; Wan X; Zhou J; Zhang Y; Ma H; Bai Y
    Int J Biol Markers; 2016 May; 31(2):e173-82. PubMed ID: 26847605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis.
    Li J; Cui Z; Li H; Lv X; Gao M; Yang Z; Bi Y; Zhang Z; Wang S; Zhou B; Yin Z
    Cancer Cell Int; 2018; 18():109. PubMed ID: 30093838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
    Wei Y; Niu B
    Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of long non-coding RNA MALAT1 in cancer patients.
    Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D
    Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of the long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in various cancers: A meta-analysis.
    Yan J; Zhou X; Dang Y; Yin C; Zhang G
    Mol Clin Oncol; 2016 Jan; 4(1):100-106. PubMed ID: 26870366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
    Xue Y; Teng YQ; Zhou JD; Rui YJ
    Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways and role of MALAT1 in esophageal and gastric cancer.
    Syllaios A; Moris D; Karachaliou GS; Sakellariou S; Karavokyros I; Gazouli M; Schizas D
    Oncol Lett; 2021 May; 21(5):343. PubMed ID: 33747200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
    Pang EJ; Yang R; Fu XB; Liu YF
    Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis.
    Sun C; Ding Y; Wang S; Hu W
    Pathol Oncol Res; 2019 Jan; 25(1):89-95. PubMed ID: 28965279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of the clinicopathological significance of the lncRNA MALAT1 in human gastric cancer.
    Bai S; Guo J; Zhang H
    Front Oncol; 2023; 13():1257120. PubMed ID: 38239645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
    Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
    Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.